id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0313-0007,FDA,FDA-2014-D-0313,"Meetings With the Office of Orphan Products Development; Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff",Other,Guidance,2015-07-09T04:00:00Z,2015,7,2015-07-09T04:00:00Z,,2024-11-11T21:05:24Z,,1,0,0900006481b75ce1
FDA-2014-D-0313-0006,FDA,FDA-2014-D-0313,"Meetings With the Office of Orphan Products Development; Guidance 
for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2015-07-09T04:00:00Z,2015,7,2015-07-09T04:00:00Z,,2015-07-09T16:35:22Z,2015-16773,0,0,0900006481b75425
FDA-2014-D-0313-0005,FDA,FDA-2014-D-0313,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry, Researchers,
Patient Groups, and FDA Staff on Meetings With the Office of Orphan
Products Development",Notice,Notice of Approval,2015-06-03T04:00:00Z,2015,6,2015-06-03T04:00:00Z,,2015-07-09T14:25:45Z,2015-13472,0,0,0900006481b17b77